» Articles » PMID: 37113254

Improving Adherence and Health Outcomes in Testicular Cancer Survivors Using a Mobile Health-based Intervention: A Mixed-methods Pilot Study

Overview
Journal Digit Health
Date 2023 Apr 28
PMID 37113254
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Testicular cancer (TC) is one of the most common cancers among young men, with survival rates exceeding 97% due to effective treatments. Post-treatment follow-up care is important for long-term survival and monitoring psychosocial symptoms, yet TC survivors (TCS) show poor adherence to post-treatment care. Mobile-health-based interventions show high acceptability in men with cancer. This study will examine the feasibility of using the Zamplo health app to improve adherence to post-treatment care and support psychosocial outcomes in TCS.

Methods: This mixed-methods, longitudinal, single-arm pilot study will recruit N = 30 patients with a diagnosis of TC who finished treatment within ≤ 6 months and are currently aged ≥18 years old. Adherence to follow-up appointments (e.g. blood work, scans) will be assessed (primary outcome), and measures for fatigue, depression, anxiety, sexual satisfaction and function, social roles satisfaction, general mental and physical health and body image (secondary outcomes) will be completed at four-time points: baseline, 3, 6 and 12 months. One-on-one semi-structured interviews will be conducted post-intervention (month 12).

Results: Improvements in post-treatment follow-up appointment adherence and psychosocial outcomes will be analyzed using descriptive statistics, paired samples t-tests to determine changes across time points 1 through 4, and correlation analysis. Qualitative data will be analyzed using thematic analysis.

Conclusion: Findings will inform future, larger trials that incorporate evaluation of sustainability and economic implications to improve adherence to TC follow-up guidelines. Findings will be disseminated via infographics, social media, publications and presentations conducted in partnership with TC support organizations and at conferences.

Citing Articles

SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).

Arranz Arija J, Garcia Del Muro X, Caro R, Mendez-Vidal M, Perez-Valderrama B, Aparicio J Clin Transl Oncol. 2024; 26(11):2783-2799.

PMID: 38958901 PMC: 11467073. DOI: 10.1007/s12094-024-03532-2.

References
1.
Buchler T, Kubankova P, Boublikova L, Donatova Z, Foldyna M, Kanakova J . Detection of second malignancies during long-term follow-up of testicular cancer survivors. Cancer. 2011; 117(18):4212-8. DOI: 10.1002/cncr.26039. View

2.
Kenfield S, Van Blarigan E, Ameli N, Lavaki E, Cedars B, Paciorek A . Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019; 75(6):950-958. DOI: 10.1016/j.eururo.2018.12.040. View

3.
Cessna J, Jim H, Sutton S, Asvat Y, Small B, Salsman J . Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016; 81:9-13. PMC: 4822706. DOI: 10.1016/j.jpsychores.2015.12.002. View

4.
Hopwood P, Fletcher I, Lee A, Al Ghazal S . A body image scale for use with cancer patients. Eur J Cancer. 2001; 37(2):189-97. DOI: 10.1016/s0959-8049(00)00353-1. View

5.
Holland J, Kelly B, Weinberger M . Why psychosocial care is difficult to integrate into routine cancer care: stigma is the elephant in the room. J Natl Compr Canc Netw. 2010; 8(4):362-6. DOI: 10.6004/jnccn.2010.0028. View